Marcus Evans announces The Evolution Summit, taking place September 28-29, 2026 at Park Hyatt Aviara Resort, Golf Club & Spa, San Diego, CA. Designed as an invitation-only, premium forum, the Summit convenes leading clinical trial executives alongside innovative suppliers and solution providers to address the operational realities and emerging opportunities reshaping clinical research and drug development.
The Evolution Summit is structured around a dynamic agenda of visionary keynote presentations, real-life case studies, and interactive forums, supported by expert moderation. The content is aligned with key industry challenges, relevant market developments, and practical strategies adopted by organizations driving measurable progress in clinical operations.
A distinguished speaker line-up reflects the breadth of perspectives required to advance trial performance and patient access. Featured participants include Sarah Hamirani, Portfolio Director at AbbVie, and Angela DeLuca, AVP of Global Study Operations at Amgen. The program also highlights Minal Nade-Kulkarni(AstraZeneca), Nikki Amaratunge (AbbVie), and Amuche Anakor (Johnson & Johnson Innovative Medicine), serving as dynamic contributors. Additional senior leaders include Kimberly Futch (Tanabe Pharma America), Jen Watts (Aurion Biotech), Tara Lehner (INmune Bio Inc.), Nishtha Jain (CSL Behring), Milosz Blyszczek (Aquestive Therapeutics), Steven Lo (Vaxart, Inc.), Caroline Jones (Gilead Sciences), Namita Mittal Pande (Pfizer), Tatyana Matveeva (Harvard Medical School and Massachusetts General Hospital), Olisaemeka Osefoh (Keenova Therapeutics), and Haley Goodwin (Aurion Biotech). The Summit also features patient advocacy expertise from Adrienne Nicole, Lupus Patient Advocate.
The 2026 agenda will explore six central themes: Tech and AI in Clinical Trials, harnessing AI and digital tools to optimize operations, improve decision-making and enhance trial efficiency; Patient Recruitment and Experience, advancing strategies to engage participants, improve retention and create patient-centric trials; Regulatory Shifts, ICH Updates and the Clinical Impact, navigating evolving FDA changes and ICH updates to adapt trial design and operations; Partnerships and Collaboration, building stronger relationships with clinical sites, vendors and external stakeholders; Budgeting and Resource Management, optimizing trial budgets and implementing strategies to reduce cost overruns while maintaining quality; and Accelerating Timelines, employing operational strategies and innovative approaches to reduce trial timelines and speed development.
With more than 40 years of experience producing premium business events, marcus evans delivers high-quality, sector-focused forums supported by proprietary analysis of executive priorities. The organization employs 3,000 professionals across 59 worldwide locations, providing up-to-the-minute intelligence for businesses and professionals globally.
Media Contact
Stavros Karelidis, Senior Marketing Manager
Phone: 646-741-3059
Email: stavroska@marcusevanscy.com
